Details
Stereochemistry | ACHIRAL |
Molecular Formula | C21H25NO2.ClH |
Molecular Weight | 359.89 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(=O)OC1(CCN(CCC2=CC=CC=C2)CC1)C3=CC=CC=C3
InChI
InChIKey=WQUUPFMHEQIXIV-UHFFFAOYSA-N
InChI=1S/C21H25NO2.ClH/c1-18(23)24-21(20-10-6-3-7-11-20)13-16-22(17-14-21)15-12-19-8-4-2-5-9-19;/h2-11H,12-17H2,1H3;1H
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12006905
Curator's Comment: Known to be CNS active in mice. Drug of abuse.
Originator
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12006905 |
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14406754
In a "hot plate" method compound was injected into mice subcutaneously. EC50 in the test was 6.9 ug/kg
Route of Administration:
Other
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
860229-23-8
Created by
admin on Sat Dec 16 11:28:10 GMT 2023 , Edited by admin on Sat Dec 16 11:28:10 GMT 2023
|
PRIMARY | |||
|
QMW2FF5DH3
Created by
admin on Sat Dec 16 11:28:10 GMT 2023 , Edited by admin on Sat Dec 16 11:28:10 GMT 2023
|
PRIMARY | |||
|
139593546
Created by
admin on Sat Dec 16 11:28:10 GMT 2023 , Edited by admin on Sat Dec 16 11:28:10 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD